Nusca, A.; Piccirillo, F.; Bernardini, F.; De Filippis, A.; Coletti, F.; Mangiacapra, F.; Ricottini, E.; Melfi, R.; Gallo, P.; Cammalleri, V.;
et al. Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data. Int. J. Mol. Sci. 2022, 23, 7261.
https://doi.org/10.3390/ijms23137261
AMA Style
Nusca A, Piccirillo F, Bernardini F, De Filippis A, Coletti F, Mangiacapra F, Ricottini E, Melfi R, Gallo P, Cammalleri V,
et al. Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data. International Journal of Molecular Sciences. 2022; 23(13):7261.
https://doi.org/10.3390/ijms23137261
Chicago/Turabian Style
Nusca, Annunziata, Francesco Piccirillo, Federico Bernardini, Aurelio De Filippis, Federica Coletti, Fabio Mangiacapra, Elisabetta Ricottini, Rosetta Melfi, Paolo Gallo, Valeria Cammalleri,
and et al. 2022. "Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data" International Journal of Molecular Sciences 23, no. 13: 7261.
https://doi.org/10.3390/ijms23137261
APA Style
Nusca, A., Piccirillo, F., Bernardini, F., De Filippis, A., Coletti, F., Mangiacapra, F., Ricottini, E., Melfi, R., Gallo, P., Cammalleri, V., Napoli, N., Ussia, G. P., & Grigioni, F.
(2022). Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data. International Journal of Molecular Sciences, 23(13), 7261.
https://doi.org/10.3390/ijms23137261
